ArticleArchives of gynecology and obstetrics2022

Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin.

Ginevra Mills et al.PubMed ↗Publisher ↗

No numbers read from the abstract.